Molecular determinants of the cytotoxicity of platinum compounds: The contribution of in silico researchVEKRIS, Antoine; MEYNARD, Delphine; HAAZ, Marie-Christine et al.Cancer research (Baltimore). 2004, Vol 64, Num 1, pp 356-362, issn 0008-5472, 7 p.Article

Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancersMUGGIA, Franco M.Seminars in oncology. 2004, Vol 31, Num 6, pp 17-24, issn 0093-7754, 8 p., SUP14Article

Lead minerals and compoundsSMITH, J. F.American Ceramic Society bulletin. 1994, Vol 73, Num 6, pp 107-108, issn 0002-7812Article

The development of platinum compounds and their possible combinationPASETTO, Lara Maria; D'ANDREA, Mario Rosario; BRANDES, Alba Ariela et al.Critical reviews in oncology/hematology. 2006, Vol 60, Num 1, pp 59-75, issn 1040-8428, 17 p.Article

Preclinical perspectives on the use of platinum compounds in cancer chemotherapyFARRELL, Nicholas P.Seminars in oncology. 2004, Vol 31, Num 6, pp 1-9, issn 0093-7754, 9 p., SUP14Article

Chemotherapy-induced neuropathy: A comprehensive surveyMILTENBURG, N. C; BOOGERD, W.Cancer treatment reviews. 2014, Vol 40, Num 7, pp 872-882, issn 0305-7372, 11 p.Article

E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cellsCHEN HU; ZOU, Mei-Juan; LI ZHAO et al.Toxicology letters. 2012, Vol 210, Num 1, pp 78-86, issn 0378-4274, 9 p.Article

Prevention of Intrahepatic Distant Recurrence by Transcatheter Arterial Infusion Chemotherapy With Platinum Agents for Stage 1/11 Hepatocellular CarcinomaISHIKAWA, Toru; HIGUCHI, Kazuo; KUBOTA, Tomoyuki et al.Cancer. 2011, Vol 117, Num 17, pp 4018-4025, issn 0008-543X, 8 p.Article

The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellumCERRI, Silvia; PICCOLINI, Valeria M; SANTIN, Giada et al.Neurotoxicology and teratology. 2011, Vol 33, Num 2, pp 273-281, issn 0892-0362, 9 p.Article

Following the Synthesis of Metal Nanoparticles within pH-Responsive Microgel Particles by SAXSPAVLOPOULOU, E; PORTALE, G; CHRISTODOULAKIS, K. E et al.Macromolecules (Print). 2010, Vol 43, Num 23, pp 9828-9836, issn 0024-9297, 9 p.Article

Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitroYANAGIE, Hironobu; HISA, Tomoyuki; KIDANI, Yosinori et al.Biomedicine & pharmacotherapy. 2009, Vol 63, Num 8, pp 553-560, issn 0753-3322, 8 p.Article

In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort studyHEE SEUNG KIM; TAE JOONG KIM; HYUN HOON CHUNG et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 11, pp 1513-1520, issn 0171-5216, 8 p.Article

The Renaissance of Platinum-Based Chemotherapy for Metastatic Breast CancerMERIGGI, F; DI BIASI, B; ZANIBONI, A et al.Journal of chemotherapy (Testo stampato). 2008, Vol 20, Num 5, pp 551-560, issn 1120-009X, 10 p.Article

Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC-ICP-MSHANN, S; STEFANKA, Zs; LENZ, K et al.Analytical and bioanalytical chemistry. 2005, Vol 381, Num 2, pp 405-412, 8 p.Conference Paper

Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancersHALLER, Daniel G.Seminars in oncology. 2004, Vol 31, Num 6, pp 10-16, issn 0093-7754, 7 p., SUP14Article

Optimal treatment for ovarian cancer: taxoids and beyondVERMORKEN, Jan B.Annals of oncology. 2000, Vol 11, pp 131-139, issn 0923-7534, SUP3Conference Paper

A remarkable synergic effect of water-soluble bimetallic catalyst in the hydrogenation of aromatic nitrocompoundsHENG JIANG; YUN XU; SHIJIAN LIAO et al.Journal of molecular catalysis. A, Chemical. 1999, Vol 142, Num 2, pp 147-152, issn 1381-1169Article

Heritable and cancer risks of exposures to anticancer drugs : inter-species comparisons of covalent deoxyribonucleic acid-binding agentsVOGEL, E. W; BARBIN, A; NIVARD, M. J. M et al.Mutation research. 1998, Vol 400, Num 1-2, pp 509-540, issn 0027-5107Article

In vivo models of occupational asthma due to low molecular weight chemicalsHAYES, J. P; TAYLOR, A. J. N.Occupational and environmental medicine (London). 1995, Vol 52, Num 8, pp 539-543, issn 1351-0711Article

Synthesis of Perovskite lead magnesium niobate using partial oxalate methodGUPTA, S. M; KULKARNI, A. R.Materials research bulletin. 1993, Vol 28, Num 12, pp 1295-1301, issn 0025-5408Article

Analysis of UvrABC endonuclease reaction intermediates on cisplatin-damaged DNA using mobility shift gel electrophoresisVISSES, R; DE RUIFTER, M; MOOLENAAR, G. F et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 10, pp 6736-6742, issn 0021-9258Article

Material performance in hot waste gases derived from a lead recovery furnace = Performances des matériaux dans les gaz perdus chauds dérivés d'un four de récupération de plombPRESCOTT, R; ELLIOTT, P.Materials performance. 1988, Vol 27, Num 5, pp 28-33, issn 0094-1492Article

Glioblastoma Treatment: Bypassing the Toxicity of Platinum Compounds by Using Liposomal Formulation and Increasing Treatment Efficiency With Concomitant RadiotherapyCHAREST, Gabriel; SANCHE, Léon; FORTIN, David et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 1, pp 244-249, issn 0360-3016, 6 p.Article

Polyaniline stabilized highly dispersed Pt nanoparticles: Preparation, characterization and catalytic propertiesDRELINKIEWICZ, A; ZIEBA, A; SOBCZAK, J. W et al.Reactive & functional polymers. 2009, Vol 69, Num 8, pp 630-642, issn 1381-5148, 13 p.Article

Polymeric Drug Delivery of Platinum-Based Anticancer AgentsHAXTON, Katherine J; BURT, Helen M.Journal of pharmaceutical sciences. 2009, Vol 98, Num 7, pp 2299-2316, issn 0022-3549, 18 p.Article